Biomarkers in Gastrointestinal Cancers

Badreddine, Rami; Wang, Kenneth K.
August 2008
American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p2106
Academic Journal
The article focuses on the use of biomarkers in gastrointestinal (GI) cancers. The prevalence of an ideal biomarker should be low in precancerous lesions and should go up in early cancer stages like dysplasia. The biomarkers in GI cancers are useful for diagnosis, screening and prognosis and for the prediction of the response to mechanism-based interventions such as chemoprevention.


Related Articles

  • CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer. Se-Il Go; Gyung Hyuck Ko; Won Sup Lee; Rock Bum Kim; Jeong-Hee Lee; Sang-Ho Jeong; Young-Joon Lee; Soon Chan Hong; Woo Song Ha // Cancer Research & Treatment;2016, Vol. 48 Issue 1, p142 

    Purpose: The present study is to investigate the significance of CD44 variant 9 (CD44v9) expression as a biomarker in primary gastric cancer. Materials and Methods: With various gastric tissues, we performed immunohistochemical staining for CD44v9. Results: The positive expression rates for...

  • Evaluating tumor angiogenesis, lymphangiogenesis helpful. Petrou, Ilya // Dermatology Times;Nov2006, Vol. 27 Issue 11, p94 

    The article focuses on the significance of tumor thickness in specifying the prognosis of patients suffering from malignant melanoma. It was found out that accurate tumor markers such as the lymphagiogenesis are necessary in estimating the potential metastasis and permitting the precise...

  • Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm. DAS, CHHANDA; MUKHOPADHYAY, MADHUMITA; GHOSH, TARUN; SAHA, ASHIS KUMAR; SENGUPTA, MOUMITA // Journal of Clinical & Diagnostic Research;Mar2014, Vol. 8 Issue 3, p41 

    Context or Background: CA125 is a biomarker that has potential utility across the spectrum: risk assessment, early detection, diagnosis, prognosis, monitoring and therapy. Aims and Objectives: This study was conducted to establish the validity and reliability of correlation of CA125 serum level...

  • High throughput immunosenor based on multi-label strategy and a novel array electrode. Zhe-Han Yang; Ying Zhuo; Ya-Qin Chai; Ruo Yuan // Scientific Reports;4/25/2014, p1 

    Accurate prediction of a particular cancer can be achieved by measuring multiplex biomarkers. Traditional methods for multi-biomarkers detection are either multi-spots assay with chip or multi-label assay with one detection spot. However, the detection throughput of these two approaches is...

  • Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Cai, Hui; Yuan, Yuan; Hao, Yun-Fei; Guo, Tian-Kang; Wei, Xue; Zhang, Ying-Mei // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Recent studies have shown that microRNAs can be stably detected in human plasma and have the potential as non-invasive biomarkers for the diagnosis of cancers. This study evaluates the potential application of plasma microRNAs for the early detection of gastric cancer (GC). We first measured the...

  • Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer. Culhane, A. C.; Howlin, J. // Cellular & Molecular Life Sciences;Dec2007, Vol. 64 Issue 24, p3185 

    Utilisation of ‘omics’ technologies, in particular gene expression profiling, has increased dramatically in recent years. In basic research, high-throughput profiling applications are increasingly used and may now even be considered standard research tools. In the clinic, there is a...

  • Regulatory T cells and cancer: an undesired tolerance. Ducloux, Didier // Kidney International;Jul2014, Vol. 86 Issue 1, p16 

    The incidence of cancer is markedly increased in organ transplant patients. A better understanding of underlying mechanisms and the identification of biomarkers for diagnosis and prognosis are major challenges. Hope et al. report expansion of regulatory T cells to be associated with the presence...

  • Circulating MicroRNAs: Potential Biomarkers for Cancer. De-Cai Yu; Qing-Guo Li; Xi-Wei Ding; Yi-Tao Ding // International Journal of Molecular Sciences;Mar2011, Vol. 12 Issue 3, p2055 

    Cancer is the leading cause of death in the world. Development of minimally invasive biomarkers for early detection of cancer is urgently needed to reduce high morbidity and mortality associated with malignancy. MicroRNAs (miRNAs) are small regulatory RNAs that modulate the activity of specific...

  • Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior. Isic Dencic, Tijana; Cvejic, Dubravka; Paunovic, Ivan; Tatic, Svetislav; Havelka, Marija; Savin, Svetlana // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Cytokeratin19 (CK19) has been reported as a useful marker of thyroid tumors. We evaluated its value for differential diagnosis of thyroid neoplastic lesions and assessed its usefulness for predicting aggressive behavior of papillary thyroid carcinomas by correlating immunohistochemical results...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics